Mode
Text Size
Log in / Sign up
N/A N=9 Treatment

Narrative Exposure Therapy (NET)

Posttraumatic Stress Disorder

Enrolled (actual)
9
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcome: Primary: PTSD Checklist for the DSM-5 (PCL-5) — 47.8; 25.0; 20; -22.8 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Narrative Exposure Therapy for Justice-Involved Veterans (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Feb 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
PTSD Checklist for the DSM-5 (PCL-5)
47.8; 25.0; 20; -22.8; -25.8
PRIMARY
Dimensions of Anger Reactions (DAR)
32; 37.8; 18.3; 5.8; -9.5
PRIMARY
The Appetitive Aggression Scale (AAS)
8.6; 7.8; -0.8
PRIMARY
Beck Depression Inventory (BDI-2)
19.2; 13.2; 11.3; -6; -5.8
SECONDARY
The Moral Injury Events Scale (MIES)
60.4; 63.6; 61.3; 3.2; -4.3
SECONDARY
Revised Conflict Tactics Scales (CTS2)
8.6; 8.6; 1.8; 0.0; -6.5; 3.4
SECONDARY
Trauma-Related Guilt Index (TRGI)
SECONDARY
Interpersonal Needs Questionnaire (INQ)
48.6; 36.0; 25.0; -12.6; -19.3

Summary

The purpose of this study is to learn more about Narrative Exposure Therapy for Justice Involved Veterans. This pilot study will examine the feasibility of this intervention in a justice-involved veteran population, and will see whether the intervention needs to be tailored to best meet their needs. The investigators will examine whether the intervention impacts key clinical outcomes, including posttraumatic stress disorder symptoms, as well as on measures of moral injury, anger, depression, suicidality, and aggression.

Eligibility Criteria

Inclusion Criteria

  • Is a veteran;
  • Recent justice involvement including current probation, parole, or house arrest, or having been released from jail or prison within the past 1 year;
  • Meets current criteria for PTSD.

Exclusion Criteria

  • Currently incarcerated;
  • Current, active psychosis;
  • Is at imminent risk for suicide or homicide warranting immediate intervention;
  • Substance abuse that is severe enough to prevent full engagement in the study protocol;
  • Concurrent trauma-focused psychotherapy including Prolonged Exposure Therapy, Cognitive Processing Therapy, or EMDR;
  • Is unable to unwilling to complete study procedures.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03777553). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search